NCT06268249View on ClinicalTrials.gov

Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction

CompletedOBSERVATIONAL
Enrollment

7,065

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2023

Conditions
Postoperative Cognitive DysfunctionPostoperative Delirium
Interventions
DRUG

Ulinastatin

Ulinastatin was pumped continuously during the operation

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Qin Zhang

OTHER

NCT06268249 - Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction | Biotech Hunter | Biotech Hunter